EFTA02030553.pdf

To: jeeyacation©gmail.comfjeeyacation©gmail.cont, jeeyacation maitcom 'eeyaeation mail.com] From: Sent Sun 12/25/2011 6:04:09 PM Subject Re: Hi Jeffrey Is there a good time to check-in with you to get your feedback on the budget we sent you two weeks ago and on what issues would interest you in developing a partnership with our efforts in placebo studies? We're trying to think bot scientifically and strategically. Our team has all the intellectual and infrastructure resources of Harvard University and any input would be appreciated. Best, ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote: now On Mon, Dec 5, 2011 at 1:26 PM, wrote: I tried calling you on November 28. No answer. Our work is getting enormous media attention. (Attached is an article in this week's New EFTA_R1_00540314 EFTA02030553  Yorker. I wished it had focused more on our science and less on me. We expect coverage by "60 Minutes" in January.) This is a critical time to develop our scientific and institutional roots at Harvard. We're looking for partners to help move our research along. Would there be another time you could talk by telephone? Best ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone: Email: Web: www.programinplacebostudies.org * ************************************** ******************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00540315 EFTA02030554